Status:
COMPLETED
Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborating Sponsors:
Carlos III Health Institute
Spanish Clinical Research Network - SCReN
Conditions:
Femur Fracture
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
National, randomized, open, parallel, multicenter clinical trial of two comparison groups that will evaluate the feasibility of a strategy based on a diagnostic test to shorten the surgery time in ant...
Eligibility Criteria
Inclusion
- Patients older than 18 years
- Patients of both sexes
- Patients with a proximal femoral fracture requiring surgery
- Patients receiving antiplatelet agents at the time of admission to the emergency room: AAS\> 100 mg / d (Aspirin®), Trifusal\> 300 mg / d (Digren®; Edigen®), clopidogrel (Plavix®), prasugrel ®), ticagrelor (Brilique ®) and ticlopidine (Tiklid ®).
- Patients who give their signed consent
Exclusion
- Multiple fractures
- Pathological fractures
- Patients receiving vitamin K antagonist oral anticoagulants (warfarin and acenocoumarol) or new oral anticoagulants (apixaban, rivaroxaban and dabigatran) or who have acquired congenital or acquired coagulopathy
- Patients with AAS ≤100mg, trifusal ≤300mg
- Patients who do not give their informed consent or their legal guardian
Key Trial Info
Start Date :
September 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 17 2021
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT03231787
Start Date
September 4 2017
End Date
December 17 2021
Last Update
January 19 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Althaia, Xarxa Assistencial Universitària de Manresa
Manresa, Barcelona, Spain
2
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
3
Hospital Vall d'Hebron
Barcelona, Spain